Regard
AI clinical insights platform that surfaces patient history context and documentation before physician review.
Last updated: June 5, 2026
Back to directoryClinical data management AI platform for registry abstraction, evidence-linked chart answers, provenance, and human-validated abstraction workflows.
Hospitals and health systems with costly registry abstraction backlogs, quality-reporting workflows, and clinical data management teams that need evidence-linked abstraction support.
Compare within workflow: Clinical operations and revenue cycle · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Carta Healthcare Voyager as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Primarily clinical data management and quality registry workflow software, but treat registry submission, quality reporting, research cohorting, and patient-care analytics as high-accountability outputs requiring local governance. |
|---|---|
| Privacy | Confirm dedicated deployment, FHIR scope, AWS Bedrock and model-vendor terms, BAA coverage, SOC 2 scope, encryption, retention, access controls, audit logs, and whether any data is reused for product improvement. |
| Evidence | Require field-level source evidence and compare AI-assisted abstraction against local abstractors for accuracy, IRR, missed data, hallucinated facts, and registry-specific edge cases. |
| Workflow | Best deployed as hybrid intelligence with named abstractor review, submission controls, exception queues, registry change management, and audit sampling before scaling. |
Carta Healthcare describes Voyager as an AI platform for clinical data abstraction with FHIR access, supporting evidence, data provenance, human validation, AWS Bedrock hosting, customer data isolation, SOC 2 audits, HIPAA BAAs, and no customer-data training of external models.
Not for: Fully autonomous quality reporting, clinical diagnosis, registry submission, or research cohort decisions without abstractor review and audit controls.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.